Table 1.
No | Genes or gene family |
Proteins or complex | Mutant | p53-wt Cell phenotypea | p53-null Cell phenotypea |
p53-wt Plk1-depleted cell phenotypea | p53-null Plk1-depleted cell phenotypea |
Data and source |
---|---|---|---|---|---|---|---|---|
1 |
CCNB1 & CCNB2 |
Cyclin B | Cyclin B-null | Inviable | Inviable | Inviable | Inviable | Inviable65,66 |
2 | CDKN1A | p21 | p21-null |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.3 |
Viable Tm/T = 1.9 |
Viable67 |
3 | CDC25 | Cdc25 | cdc25-null | Inviable | Inviable | Inviable | Inviable | Inviable68 |
4 | WEE1 | Wee1 | wee1-null | Inviable | Inviable | Inviable | Inviable | Inviable69 |
5 | PLK1 | Plk1 | plk1-null | Inviable | Inviable | Inviable | Inviable | Inviable55 |
6 | PP2A | PP2A | PP2A-null | Inviable | Inviable | Inviable | Inviable | Inviable70 |
7 | ANAPC1 | APC/C | APC-null | Inviable | Inviable | Inviable | Inviable | Inviable71 |
8 | CDC20 | Cdc20 | cdc20 -null | Inviable | Inviable | Inviable | Inviable | Inviable72 |
9 | CDH1 | Cdh1 | cdh1-null |
Viable Tm/T = 0.3 |
Viable Tm/T = 0.3 |
Viable Tm/T = 0.3 |
Inviable | Suppression by RNAi is viable73 |
10 | PTTG1 | Pttg1 | pttg1-null |
Viable Tm/T = 1.1 |
Viable Tm/T = 1.1 |
Viable Tm/T = 1.6 |
Viable Tm/T = 2.1 |
Viable74 |
11 | ATM | ATM | ATM-null |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.4 |
Viable Tm/T = 1.4 |
Viable75 |
12 | TP53 | p53 | p53-null |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.8 |
Viable Tm/T = 1.8 |
Viable55 |
13 | MAD2L1 | Mad2 | mad2-null |
Viable Tm/T = 1.0 |
Viable Tm/T = 1.0 |
Viable, Tm/T = 1.4 |
Viable Tm/T = 1.8 |
Viable76 |
14 | CDH1 & CDKN1A | Cdh1 & p21 | cdh1-null p21-null | Inviable | Inviable | Inviable | Inviable | Prediction |
15 | CDKN1A PP2A | p21 & PP2A | p21-null PP2A-null | Inviable | Inviable | Inviable | Inviable | Prediction |
16 | CDKN1A WEE1 | p21 & Wee1 | p21-null wee1-null | Inviable | Inviable | Inviable | Inviable | Prediction |
17 | CDKN1A PTTG1 | p21 & Pttg1 | p21-null pttg1-null |
Viable Tm/T = 1.1 |
Viable Tm/T = 1.1 |
Viable Tm/T = 1.6 |
Viable Tm/T = 2.2 |
Prediction |
18 | CDH1 MAD2 | Cdh1 & Mad2 | cdh1-null mad2-null | Inviable | Inviable |
Viable Tm/T = 0.3 |
Viable Tm/T = 0.3 |
Prediction |
19 | CDC20 PTTG1 | Cdc20 & Pttg1 | cdc20-null pttg1-null | Inviable | Inviable | Inviable | Inviable | Prediction |
20 | CDC20 MAD2 | Cdc20 & Mad2 | cdc20-null mad2-null | Inviable | Inviable | Inviable | Inviable | Prediction |
21 | PP2A MAD2 | PP2A & Mad2 | PP2A-null mad2-null | Inviable | Inviable | Inviable | Inviable | Prediction |
22 | PP2A PTTG1 | PP2A & Pttg1 | PP2A-null pttg1-null | Inviable | Inviable | Inviable | Inviable | Prediction |
23 | CDC25 WEE1 | Cdc25 & Wee1 | cdc25-null wee1-null | Inviable | Inviable | Inviable | Inviable | Prediction |
aTm/T is the ratio of cell cycle periods observed in the mutants Tm and in wild-type cancer cells T.